Dermata Therapeutics Stock Forecast

Sell candidate since Jun 05, 2026

The Dermata Therapeutics, Inc. stock price gained 24.55% on the last trading day (Friday, 5th Jun 2026), rising from $0.0110 to $0.0137. During the last trading day the stock fluctuated 84.68% from a day low at $0.0124 to a day high of $0.0229. The price has been going up and down for this period, and there has been a 8.73% gain for the last 2 weeks. Volume fell on the last day by -7 thousand shares and in total, 206 shares were bought and sold for approximately $2.82 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.12% during the next 3 months and, with a 90% probability hold a price between $0.0061 and $0.0127 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

DRMAW Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 04, 2026, and so far it has risen 24.55%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dermata Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0140. On a fall, the stock will find some support from the short-term average at $0.0134. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

Dermata Therapeutics, Inc. finds support from accumulated volume at $0.0131 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0105 between high and low, or 84.68%. For the last week the stock has had daily average volatility of 53.45%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DRMAW) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Dermata Therapeutics, Inc. to open at $0.0163, and during the day (based on 14 day Average True Range), to move between $0.0112 and $0.0162, which gives a possible trading interval of +/-$0.0049 (+/-43.86%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 43.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0131 (4.38%) than the resistance at $0.0154 (12.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.223 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.0163 ( 19.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk